COMPANY
Spiro Medical
Funding and NIH signals
- SEC Form D raise Raised $37.1M (Form D filed Jan 5, 2026). SEC Form D 0001996433-26-000001 (Jan 5, 2026)
Evidence (1 event)
- Jan 5, 2026 · SEC Form D 0001996433-26-000001
Name of Issuer: Spiro Medical Inc.; CIK: 1996433; Address: Belleair Bluffs, FL; Submission type: D; Filing date: 2026-01-05; Industry Group: Other Health Care; Date of First Sale: 2025-12-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 69095598; Total Amount Sold: 37095655; Federal exemptions: 06b
- Jan 5, 2026 · SEC Form D 0001996433-26-000001
Timeline
- Trial start Not phased (device or behavioral study): PULmonary Stimulation for Asthma Relief source ↗
Upcoming milestones
- 2027-01 (ESTIMATED) · Not phased · PULmonary Stimulation for Asthma Relief · NCT07709754
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07709754 | PULmonary Stimulation for Asthma Relief | Not phased (device or behavioral study) | Recruiting | Aug 30, 2026 | 2027-01 (estimated) |